{"id":"NCT01309386","sponsor":"Janssen Pharmaceutical K.K.","briefTitle":"A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants","officialTitle":"A Randomized, Open-Label, Parallel-Arm, Optimal Dose-Titration, Multicenter Study to Evaluate the Safety and Efficacy of Oral JNS024 Extended-Release (ER) in Japanese Subjects Treated With Around-the-Clock Opioid Analgesics for Their Moderate to Severe Chronic Malignant Tumor- Related Cancer Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-08","primaryCompletion":"2012-01","completion":"2012-01","firstPosted":"2011-03-07","resultsPosted":"2013-03-13","lastUpdate":"2013-03-13"},"enrollment":100,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Neoplasms"],"interventions":[{"type":"DRUG","name":"Tapentadol ER","otherNames":[]},{"type":"DRUG","name":"Morphine SR","otherNames":[]}],"arms":[{"label":"Tapentadol ER","type":"EXPERIMENTAL"},{"label":"Morphine SR","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the conversion rate based on the number of participants achieving pain control and safety within 1 week after switching the opioid (morphine-like medications) analgesics (drug used to control pain), when tapentadol extended-release (ER) (JNS024ER) is orally administered to participants treated with around-the-clock opioid analgesics, for their moderate to severe (very serious, life threatening) chronic (lasting a long time) malignant (cancerous) tumor-related (a mass in a specific area) cancer (abnormal tissue that grows and spreads in the body) pain.","primaryOutcome":{"measure":"Percentage of Participants Who Achieved Pain Control","timeFrame":"Week 1","effectByArm":[{"arm":"Tapentadol ER","deltaMin":84,"sd":null},{"arm":"Morphine SR","deltaMin":98,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":22,"countries":["Japan"]},"refs":{"pmids":["24906437"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":50},"commonTop":["Somnolence","Disease progression","Constipation","Nausea","Vomiting"]}}